President Donald Trump’s pick to lead the US Patent and Trademark Office is setting off alarm bells for tech companies and ...

TE Connectivity (NYSE:TEL) recently faced a legal complaint from Credo Technology Group concerning alleged patent infringements, which was a notable development affecting the company's share ...

U.S. President Donald Trump has nominated John Squires, the former chief intellectual property attorney at banking giant ...

Merck (MRK) stock trended lower as Halozyme (HALO) challenges the company over injectable Keytruda patents. Read more here.

Amphenol (NYSE:APH) saw its shares decline by 2.91% last week, coinciding with Credo Technology Group's legal actions alleging patent infringement against several companies, including Amphenol. This ...

Halozyme Therapeutics claims Merck's new Keytruda version infringes on patents, requiring a licensing agreement, reports WSJ.

Ferrari has filed a patent for an engine with pill-shaped pistons, a radical departure from traditional circular piston ...

The patent, among several owned by QIAGEN that protect the QuantiFERON technology, encompasses significant ... with the goal of covering Wall Street for a new generation of investors, RTTNews ...

Waymo's autonomous driving technology is showing significant safety improvements over human drivers. Read why GOOG stock is a ...

This action was surfaced by Law.com Radar, which delivers real-time alerting on new litigation across more than 2,600 state ...

Microsoft just rewarded its shareholders again with a dividend. This Magnificent 7 stock is on track to become a Dividend ...

the Wall Street Journal reported on Wednesday, citing people familiar with the matter. According to Halozyme, the new version of Keytruda infringes on its patents, the report said. Sign up here.